Lv11
40 积分 2024-04-22 加入
Optimization of M3 Antagonist–PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD
13分钟前
待确认
Safety, pharmacokinetics and pharmacodynamics of TQC3721, an innovative, dual PDE3 and PDE4 inhibitor, in healthy subjects and patients with chronic obstructive pulmonary disease: Randomised, double‐blind, placebo‐controlled phase I and IIa clinical trials
1个月前
已完结
Ensifentrine synergistically relaxes hyperreactive human bronchi from COPD donors in combination with ICS, LABA, and LAMA
3个月前
已关闭
[Research prospect of cyclic nucleotide phosphodiesterase 3/4 inhibitors in chronic obstructive pulmonary disease]
4个月前
已完结
Ligand bias at the muscarinic acetylcholine receptor family: Opportunities and challenges
4个月前
已完结
Identification of anatomical types of segmental bronchi in left superior and lingular lobes using multi-slice CT
5个月前
已完结
What Role will Ensifentrine Play in the Future Treatment of Chronic Obstructive Pulmonary Disease Patients? Implications from Recent Clinical Trials
5个月前
已完结
Optimization of M3 Antagonist–PDE4 Inhibitor (MAPI) Dual Pharmacology Molecules for the Treatment of COPD
5个月前
已完结
Physiological and immunological aspects of asthma: the guinea pig (Cavia porcellus) as a model of allergic asthma
7个月前
已完结
Pulmonary absorption – estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis
7个月前
已完结